Monday 19 October 2026
Export FEED’s income statement to Excel — free account
ENvue Medical, Inc.
FEED Healthcare Medical Devices
ENvue Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 51.6%, EPS grew 75.8%, free cash flow grew 19.8% and total debt fell 45.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.37
0.12
−24.49%
Follow FEED
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 6 | 2 | — | 5 | — | 3 | — | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(4.72) | (28.94) | (14.06) | (15.21) | 8,819.16 | (3.19) | 6,581.36 | (7.50) | 3,973.43 | (13.92) |
P/S ratio |
0.57 | 0.67 | 0.86 | 8.88 | 17.60 | 16.20 | 14.07 | 12.95 | 42.59 | 42.59 |
Altman Z″-Score (non-manufacturers) |
(6.20) | (68.02) | (30.22) | (35.37) | (41.09) | (18.19) | (22.62) | (16.28) | (20.13) | (71.71) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
6.64 | (3.98) | 8.67 | (2.07) | — | (6.90) | — | (1.86) | — | (6.64) |
P/Operating CF |
(0.54) | (3.13) | (4.02) | (5.02) | (34.57) | (31.81) | (6.65) | (6.12) | (21.87) | (21.87) |
P/B ratio |
0.04 | 2.73 | 0.49 | 2.07 | 4.73 | 4.35 | 3.66 | 3.37 | 16.79 | 16.79 |
Price to Tangible BV |
41.42 | 2.73 | 0.49 | 2.07 | 4.73 | 4.35 | 3.66 | 3.37 | 16.79 | 16.79 |
EV/Sales |
(0.66) | 0.39 | (0.55) | 5.35 | 13.07 | 11.68 | 2.03 | 0.92 | 43.06 | 43.06 |
EV/EBITDA |
0.16 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.18 | (0.40) | 0.35 | (0.57) | (5.07) | (4.53) | (0.37) | (0.17) | (5.89) | (5.89) |
EV/FCF |
0.18 | (0.40) | 0.35 | (0.57) | (5.07) | (4.53) | (0.37) | (0.17) | (5.88) | (5.88) |
Quick Ratio |
0.68 | 0.31 | 1.47 | 1.18 | 1.22 | 4.17 | 4.20 | 2.70 | 2.63 | 3.54 |
Current Ratio |
1.09 | 1.22 | 2.64 | 2.42 | 2.42 | 4.38 | 4.38 | 2.75 | 2.75 | 4.49 |
Net Debt/EBITDA |
0.29 | 0.21 | 0.96 | 0.54 | 0.00 | 1.36 | 0.00 | 1.60 | 0.00 | 0.26 |
Debt/Assets |
2.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.11 | 0.50 | 0.36 | 0.10 | 0.00 | 0.20 | 0.00 | 0.12 | 0.00 | 0.29 |
Operating CF/Net income |
0.56 | 0.68 | 0.97 | 1.29 | 1.29 | 0.31 | 0.31 | 0.78 | 0.78 | 0.67 |
Capex/Depreciation |
0.00 | (3.00) | (1.00) | (3.00) | 0.00 | (1.50) | 0.00 | (1.00) | 0.00 | 0.00 |
Interest Coverage |
5.21 | (34.44) | (13.97) | (12.50) | — | (118.40) | — | (32.10) | — | (83.08) |
| (98.32%) | (160.56%) | (102.78%) | (114.14%) | 0.00% | (328.13%) | 0.00% | (231.58%) | 0.00% | (641.99%) | |
| (74.97%) | (71.92%) | (59.13%) | (75.14%) | 0.00% | (169.51%) | 0.00% | (84.29%) | 0.00% | (320.46%) | |
ROIC |
(47.18%) | 0.00% | (304.61%) | (602.40%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (32,193.75%) |
Return on Tangible Assets |
(2,297.95%) | (599.51%) | (91.86%) | (165.09%) | (161.14%) | (221.63%) | (219.96%) | (85.29%) | (84.75%) | (404.33%) |
Average Days of Receivables |
41.32 | 13.98 | 50.84 | 4.37 | 52.91 | 43.07 | 56.85 | 171.08 | 54.49 | 76.44 |
Research and Development Expense of Revenue |
69.02% | 35.54% | 8.10% | 37.63% | 37.63% | 17.29% | 17.29% | 27.45% | 27.45% | 96.98% |
Selling, General and Administrative Expense of Revenue |
396.63% | 163.45% | 209.72% | 651.06% | 651.06% | 363.42% | 363.42% | 764.37% | 764.37% | 927.92% |
Intangible Assets out of Total Assets |
0.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 13.92% | 12.83% | 47.07% | 0.00% | 22.54% | 0.00% | 151.20% | 0.00% | 331.13% |
Graham Net Nets |
(0.25) | 0.19 | 1.93 | 0.44 | 0.20 | 0.22 | 0.24 | 0.26 | 0.05 | 0.05 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1,319.20%) | (213.80%) | (185.31%) | (83.00%) | (50.75%) | (55.14%) | (50.72%) | (55.10%) | (29.84%) | (29.84%) |
Free Cash Flow Yield |
(650.59%) | (147.02%) | (182.58%) | (105.37%) | (14.65%) | (15.92%) | (38.78%) | (42.13%) | (17.20%) | (17.20%) |
Revenue per Share |
48.81 | 1,162.73 | 1,756.15 | 683.64 | 0.53 | 1,695.00 | 1.35 | 1,557.50 | 1.21 | 1,766.67 |
Operating CF per Share |
(179.20) | (1,143.64) | (2,770.77) | (6,395.45) | (4.96) | (4,367.00) | (3.47) | (8,477.50) | (6.59) | (12,913.33) |
Capex per Share |
(1.15) | (1.36) | (0.77) | (2.73) | 0.00 | (3.00) | 0.00 | (5.00) | 0.00 | 0.00 |
Free Cash Flow per Share |
(180.34) | (1,145.00) | (2,771.54) | (6,398.18) | (4.96) | (4,370.00) | (3.47) | (8,482.50) | (6.59) | (12,913.33) |
Cash per Share |
81.34 | 341.82 | 2,525.38 | 2,466.36 | 1.91 | 7,737.00 | 6.15 | 18,832.50 | 14.63 | 4,460.00 |
Shareholders Equity per Share |
640.48 | 285.00 | 3,067.69 | 2,939.09 | 2.28 | 6,313.00 | 5.02 | 5,985.00 | 4.65 | 4,493.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
640.48 | 285.00 | 3,067.69 | 2,939.09 | 2.28 | 6,313.00 | 5.02 | 5,985.00 | 4.65 | 4,493.33 |
Free Cash Flow |
(9.43) | (2.52) | (3.60) | (7.04) | (7.03) | (4.37) | (4.37) | (3.39) | (3.39) | (3.87) |
Working Capital |
0.61 | 0.61 | 4.03 | 3.29 | 3.29 | 6.44 | 6.44 | 5.07 | 5.07 | 1.43 |
Capital Expenditures |
(0.06) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Net Current Asset Value |
(0.36) | 0.33 | 3.80 | 2.96 | 2.96 | 6.03 | 6.03 | 2.14 | 2.14 | 1.15 |
EV/EBIT |
0.07 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
101.27 | 0.11 | 0.14 | 0.14 | 0.01 | 0.40 | 0.04 | 0.50 | 0.06 | 1.00 |
Cash ROIC |
(24.29%) | (182.67%) | (49.55%) | (118.37%) | 0.00% | (31.10%) | 0.00% | (34.18%) | 0.00% | (144.23%) |
Accounts Receivable Turnover |
13.19 | 12.30 | 13.96 | 7.20 | 0.00 | 6.89 | 0.00 | 3.09 | 0.00 | 5.15 |
Accounts Payable Turnover |
1.33 | 0.71 | 0.32 | 0.29 | 0.00 | 0.76 | 0.00 | 1.07 | 0.00 | 1.55 |
Inventory Turnover |
1.06 | 0.43 | 0.30 | 0.50 | 0.00 | 5.78 | 0.00 | 3.08 | 0.00 | 1.88 |
Average Days of Payables |
465.98 | 187.02 | 1,175.73 | 1,381.38 | 41.18 | 714.22 | 34.33 | 564.01 | 128.51 | 189.10 |
Days of Inventory on Hand |
355.42 | 761.63 | 1,336.70 | 1,357.05 | 1,357.05 | 69.05 | 69.05 | 129.40 | 129.40 | 177.37 |
Average Receivables |
0.19 | 0.21 | 0.16 | 0.10 | 0.15 | 0.25 | 0.28 | 0.20 | 0.10 | 0.10 |
Average Payables |
1.80 | 1.47 | 2.31 | 2.01 | 0.94 | 1.22 | 0.36 | 0.38 | 0.14 | 0.16 |
Average Inventory |
2.26 | 2.46 | 2.45 | 1.18 | 1.18 | 0.16 | 0.16 | 0.13 | 0.13 | 0.13 |
Average Assets |
22.38 | 5.15 | 6.28 | 7.25 | 7.25 | 8.43 | 8.43 | 5.13 | 5.13 | 1.81 |
Average Common Equity |
17.06 | 2.31 | 3.61 | 4.77 | 4.77 | 4.35 | 4.35 | 1.87 | 1.87 | 0.90 |
Columns are period end dates